Author:
Manka Laurie A.,Guntur Vamsi P.,Denson Joshua L.,Dunn Ryan M.,Dollin Yeshai T.,Strand Matthew J.,Wechsler Michael E.
Funder
Teva Pharmaceutical Industries
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference17 articles.
1. Prevalence of Churg–Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies;Martin;Pharmacoepidemiol Drug Saf,1999
2. Prevalence of serious eosinophilia and incidence of Churg–Strauss syndrome in a cohort of asthma patients;Loughlin;Ann Allergy Asthma Immunol,2002
3. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management;Groh;Eur J Intern Med,2015
4. TH2, allergy and group 2 innate lymphoid cells;Licona-Limón;Nat Immunol,2013
5. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献